Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Lipoprotein(a) in Cardiovascular Diseases

Insight From a Bibliometric Study

Bibliographic Data

ID22088273
AuthorsDavid Šuran (0000-0002-4073-9286, University of Maribor, corresponding author), Helena Blažun Vošner (0000-0003-1998-7346, Alma Mater Europaea), Jernej Završnik (0000-0002-5023-0483, Alma Mater Europaea), Peter Kokol (0000-0001-9102-9359, University of Maribor), Andreja Sinkovič (0000-0001-9887-6841, University of Maribor), Vojko Kanič (0000-0001-9239-2133, University of Maribor), Marko Kokol (0000-0003-4292-989X, University of Maribor), Franjo Naji (0000-0002-1425-4189, University of Maribor), Tadej Završnik (University of Maribor)
Year2022
Volume10
Pages923797-923797
Publication date2022-07-05
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2022.923797
PMID35865239
OpenAlexW4283822670
LanguageEN
References cited88

Lipoprotein(a) [Lp(a)] is a complex polymorphic lipoprotein comprised of a low-density lipoprotein particle with one molecule of apolipoprotein B100 and an additional apolipoprotein(a) connected through a disulfide bond. The serum concentration is mostly genetically determined and only modestly influenced by diet and other lifestyle modifications. In recent years it has garnered increasing attention due to its causal role in pre-mature atherosclerotic cardiovascular disease and calcific aortic valve stenosis, while novel effective therapeutic options are emerging [apolipoprotein(a) antisense oligonucleotides and ribonucleic acid interference therapy]. Bibliometric descriptive analysis and mapping of the research literature were made using Scopus built-in services. We focused on the distribution of documents, literature production dynamics, most prolific source titles, institutions, and countries. Additionally, we identified historical and influential papers using Reference Publication Year Spectrography (RPYS) and the CRExplorer software. An analysis of author keywords showed that Lp(a) was most intensively studied regarding inflammation, atherosclerosis, cardiovascular risk assessment, treatment options, and hormonal changes in post-menopausal women. The results provide a comprehensive view of the current Lp(a)-related literature with a specific interest in its role in calcific aortic valve stenosis and potential emerging pharmacological interventions. It will help the reader understand broader aspects of Lp(a) research and its translation into clinical practice

Apolipoprotein B · Bioinformatics · Biology · Cholesterol · Disease · Lipoprotein · Stenosis · Aortic Thrombus and Embolism · Atherosclerosis and Cardiovascular Diseases · Lipoproteins and Cardiovascular Health · Medicine · Internal Medicine

  • Documentation Notes

    Open Access•OLE V GROOS, Alan Pritchard•Journal of Documentation•1969

  • Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

    Open Access•William T Friedewald, Robert I Levy et al.•Clinical Chemistry•1972

  • Visualizing Bibliometric Networks

    Open Access•Nees Jan van Eck, Ludo Waltman•Measuring Scholarly Impact•2014

  • What can “thematic analysis” offer health and wellbeing researchers?

    Open Access•Braun, Victoria Clarke•International Journal of…•2014

  • Software survey

    Open Access•Nees Jan van Eck, Ludo Waltman•Scientometrics•2009

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae